Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma × Saline Solution × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Lung Neoplasms 12 Carcinoma, Non-Small-Cell Lung 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Delirium 2 Thromboembolism 1 Small Cell Lung Carcinoma 1 Respiratory Insufficiency 1 Postoperative Complications 1 Pneumonia 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Neurotoxicity Syndromes 1 Neoplasms 1 Myocardial Infarction 1 Metastatic Non-Squamous Non-Small Cell Lung Cancer 1 Mesothelioma 1 Lung Diseases 1 Inoperable Stage III Non-small Cell Lung Cancer 1 Emergence Delirium 1 Arrhythmias, Cardiac 1 Angina, Unstable 1 Agnosia 1 Acute Coronary Syndrome 1

Interventions

Pemetrexed 35 Cisplatin 30 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Fluorouracil 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05730816 2025-11-21

MAGIC-AKI

Brigham and Women's Hospital

Phase 2 Recruiting

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡